Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media

Investigative Radiology

Volumn 31, Issue 10, 1996, Pages 619-624

  Puttagunta, N Rao ^a   Gibby, Wendell A ^b   Puttagunta, Vijaya L ^a  

^a Magnetic Research Inc ^*  (United States)

^b UTAH VALLEY REGIONAL MEDICAL CENTER   (United States)

Author keywords

gadolinium; high performance liquid chromatography; Magnetic resonance imaging contrast media; stability; transmetallation

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE;

ARTICLE; BINDING KINETICS; CONTRAST ENHANCEMENT; DRUG STABILITY; METHYLATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THERMODYNAMICS;

EID: 0029813942     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199610000-00003     Document Type: Article

References (14)

1. Wedeking P, Kumar K, Tweedle MF. Dissociation of gadolinium chelates in mice: Relationship to chemical characteristics. Magn Reson Imaging 1992;10:641-648.
2. Rocklage SM, Worah D, Kim S. Metal ion release from paramagnetic chelates: What is tolerable? Magn Reson Med 1991;22: 216-221.
3. Mann JS. Stability of gadolinium complexes in vitro and in vivo. J Comput Assist Tomogr 1993; 17(suppl 1):S19-S23.
4. Nordenbo AM, Somnier FE. Acute deterioration of myasthenia gravis after intravenous administration of gadolinium DTPA. Lancet 1992;340:1168. Letter to the editor.
5. Hattner R, White DL. Gallium-67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med 1990;31:1844-1846.
6. Tien RD, Brasch RC, Jackson DE, Dillon WP. Cerebral Erdheim-Chester disease: Persistent enhancement with Gd-DTPA on MR images. Radiology 1989;172:791-792.
7. Biagi BA, Enyeart JJ. Gadolinium blocks low- and high-threshold calcium currents in pituitary cells. Am J Physiol 1990;259 (cell physiol 28):C515-C520.
8. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 1990;8:467-481.
9. Corot C, Hentsch A, Curtelin L. Interaction of gadolinium complexes with metal-dependent biological systems. Invest Radiol 1994;29(suppl 2):S164-S167.
10. Tweedle MF, Hagan JJ, Kumar K, Mantha S, Chang CA. Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imaging 1991;9:409-415.
11. Duram EJ, Ryskiewich DP. The acid dissociation constants of diethylene-triaminepentaacetic acid and the stability constants of some of its metal chelates. J Am Chem Soc 1958;80:4812-4817.
12. Hagan JJ, Taylor SC, Tweedle MF. Fluorescence detection of gadolinium chelates separated by reversed-phase high-performance liquid chromatography. Anal Chem 1988;60:514-516.
13. Gibby WA, Puttagunta NR, Smith GT, Clark S. Human comparative studies of Zn and Cu transmetallation in serum and urine of MRI contrast agents. In: Proceedings of the Society of Magnetic Resonance in Medicine 1994. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1994.
14. Tweedle MF. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 1992; 27(suppl 1):S2-S6.